Need for greater post-trial support for clinical trial participants assessing high-risk, irreversible treatments
There are increasing numbers of clinical trials assessing high-risk, irreversible treatments. Trial participants should only expect knowledge gain to society, no personal therapeutic benefit. However, participation may lead to long-term harms and prevent future therapeutic options. While some discus...
| Authors: | ; |
|---|---|
| Format: | Electronic Article |
| Language: | English |
| Check availability: | HBZ Gateway |
| Interlibrary Loan: | Interlibrary Loan for the Fachinformationsdienste (Specialized Information Services in Germany) |
| Published: |
2025
|
| In: |
Journal of medical ethics
Year: 2025, Volume: 51, Issue: 4, Pages: 268-273 |
| Online Access: |
Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |
